News | May 29, 2022
Venus Remedies registers 9.22 % growth in annual sales for FY22
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
The icare4u program features a dedicated website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers on Facebook and YouTube
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
The treatment of chorea associated with HD is within the scope of this Orphan Drug Designation
The EBUS is designed to support the diagnosis and staging of various lung disorders
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Subscribe To Our Newsletter & Stay Updated
